Vitamin D Status After Single Oral Dose of Cholecalciferol in Low Fat Meal Compared to High-fat Meal
NCT ID: NCT00968734
Last Updated: 2010-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2009-08-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Fat on Vitamin D Absorption
NCT01519986
The Effect of a Meal on Vitamin D Absorption
NCT01268176
Effect of an Inhibitor of Cholesterol Absorption on Vitamin D Levels
NCT02234544
Effect of Vitamin D Treatment on Fatigue
NCT02022475
Effect of Vitamin D Oral Supplements on 25 OH Vitamin D Levels
NCT01170494
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the same date, each group of participants received a meal and dietary supplement of vitamin D3 (cholecalciferol) after the first blood sample and a urine sample. Others samples were collected in the seventh and fourteenth day after intake the supplement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low fat meal
colecalciferol
50.000UI single oral dose
Hight fat meal
colecalciferol
50.000UI single oral dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
colecalciferol
50.000UI single oral dose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Obesity
* Malnutrition
* Liver disease
* Kidney disease or diabetes
* Use of dietary supplements containing calcium and vitamin D
* Medications
* Anticonvulsants
* Barbiturates, or steroids.
* Having performed a journey the last four months to locations near the Earth's equatorial plane, due to sun exposure that may have occurred during this period, or vacations planned during the study period.
20 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Rio Grande do Sul
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Universidade Federal do Rio Grande do Sul
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabiana Viegas Raimundo, graduation
Role: PRINCIPAL_INVESTIGATOR
Federal University of Rio Grande do Sul
Tania Weber Furlanetto, PhD
Role: STUDY_DIRECTOR
Federal University of Rio Grande do Sul
Gustavo Faulhaber, Master
Role: PRINCIPAL_INVESTIGATOR
Federal University of Rio Grande do Sul
Rosana Scalco, Master
Role: PRINCIPAL_INVESTIGATOR
Hospital de Clínicas de Porto Alegre
Leonardo Marques, Graduation
Role: PRINCIPAL_INVESTIGATOR
Hospital de Clínicas de Porto Alegre
Paula Menegatti, Graduation
Role: PRINCIPAL_INVESTIGATOR
Hospital de Clínicas de Porto Alegre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GPPG_080606
Identifier Type: -
Identifier Source: secondary_id
FIPE, CAPES
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.